SIRT1 and miR-34a-5p: Valuable Biomarkers for the Early Detection of Cognitive Impairment in Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

SIRT1 and miR-34a-5p: Valuable Biomarkers for the Early Detection of Cognitive Impairment in Type 2 Diabetes Mellitus

Published:2023-12-16 Issue: Volume: Page:
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Vezza Teresa¹^ORCID,Víctor Víctor M²³⁴^ORCID

Affiliation:

1. Servicio de Digestivo, Hospital Universitario Virgen de las Nieves , 18014 Granada , Spain

2. Service of Endocrinology and Nutrition, University Hospital Doctor Peset, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO) , 46017 Valencia , Spain

3. Department of Physiology, University of Valencia, INCLIVA , 46010 Valencia , Spain

4. CIBERehd–Department of Pharmacology, University of Valencia , 46010 Valencia , Spain

Funder

European Regional Development Fund

Generalitat Valenciana

Spanish Ministry of Science and Innovation

Carlos III Health Institute

Miguel Servet

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

https://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgad740/54908091/dgad740.pdf

Reference8 articles.

1. 12. Older adults: standards of medical care in diabetes-2020;American Diabetes Association;Diabetes Care,2020

2. Neurometabolic evidence supporting the hypothesis of increased incidence of type 3 diabetes Mellitus in the 21st century;Rorbach-Dolata;Biomed Res Int,2019

3. Alzheimer's disease and type 2 diabetes mellitus: pathophysiologic and pharmacotherapeutics links;Rojas;World J Diabetes,2021

4. SIRT1 and miR-34a-5p expression in PBMCs as potential biomarkers for type 2 diabetes patients with cognitive impairments;Xiaofeng;J Clin Endocrinol Metab,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-34a-5p Predicts the Risk of Diabetic Neuropathic Pain and Mediates Neuroinflammation in Microglia via Targeting ENPP3;Immunological Investigations;2024-09-09